| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |